Mount Sinai Discovers Recessive ReNU2 Syndrome: The Most Prevalent Recessive Neurodevelopmental Disorder to Date

Researchers discover recessive ReNU2 syndrome, a common genetic disorder caused by RNU2-2 mutations affecting thousands with neurodevelopmental delays.

By: AXL Media

Published: Mar 30, 2026, 10:33 AM EDT

Source: Information for this report was sourced from Mount Sinai Health System

A Landmark Discovery in Non-Coding Genomic Research

The traditional focus of clinical genetics has largely centered on protein-coding genes, but a new study published in Nature Genetics highlights the profound impact of the "dark matter" of the human genome. By analyzing whole-genome sequencing data from over 67,000 individuals, a Mount Sinai-led team identified a highly prevalent recessive neurodevelopmental disorder (NDD) linked to the RNU2-2 gene. This discovery is statistically significant, as the condition is estimated to be 60 percent as common as the most prevalent dominant NDD, marking a rare instance where a recessive trait reaches such high frequency within the population.

The Molecular Mechanism of U2-2 RNA Deficiency

The newly described "recessive ReNU2 syndrome" is triggered by a near-total absence of U2-2 RNA molecules. Unlike many genetic conditions that affect protein production, this disorder disrupts the functional RNA infrastructure necessary for normal brain development. While most cases occur when a child inherits one altered copy of the RNU2-2 gene from each asymptomatic parent, researchers also noted instances where spontaneous mutations contributed to the deficiency. RNA sequencing of patient blood samples confirmed that the severity of the symptoms is directly correlated with the degree of U2-2 RNA reduction.

A Broad Spectrum of Neurological Symptoms

The clinical presentation of recessive ReNU2 syndrome varies significantly among affected children, often leading to a protracted and uncertain diagnostic journey. Common indicators include developmental delays, limited speech, and low muscle tone, though more severe cases may involve epilepsy, movement disorders, and respiratory complications. Daniel Greene, PhD, the study’s lead author, emphasized that providing a molecular explanation offers profound closure for families who have spent years seeking answers for their children’s diverse and often debilitating symptoms.